Raymond James & Associates’s Westlake Chemical Partners WLKP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$424K Sell
18,900
-25,323
-57% -$575K ﹤0.01% 3201
2024
Q2
$999K Sell
44,223
-4,763
-10% -$106K ﹤0.01% 2622
2024
Q1
$1.09M Buy
48,986
+28,943
+144% +$650K ﹤0.01% 2542
2023
Q4
$434K Buy
20,043
+6,043
+43% +$132K ﹤0.01% 3037
2023
Q3
$305K Sell
14,000
-6,059
-30% -$135K ﹤0.01% 3213
2023
Q2
$435K Sell
20,059
-18,076
-47% -$396K ﹤0.01% 3022
2023
Q1
$839K Buy
38,135
+18,424
+93% +$432K ﹤0.01% 2565
2022
Q4
$463K Buy
19,711
+5,611
+40% +$127K ﹤0.01% 2955
2022
Q3
$303K Sell
14,100
-32,212
-70% -$778K ﹤0.01% 3178
2022
Q2
$1.15M Buy
46,312
+7,877
+20% +$211K ﹤0.01% 2347
2022
Q1
$1.04M Buy
38,435
+26,389
+219% +$701K ﹤0.01% 2568
2021
Q4
$324K Buy
+12,046
New +$299K ﹤0.01% 3386
2021
Q2
Sell
-15,943
Closed -$383K 4227
2021
Q1
$383K Sell
15,943
-2,827
-15% -$66.5K ﹤0.01% 3200
2020
Q4
$447K Sell
18,770
-66
-0.4% -$1.34K ﹤0.01% 2888
2020
Q3
$353K Buy
18,836
+911
+5% +$18.1K ﹤0.01% 2849
2020
Q2
$339K Buy
17,925
+3,220
+22% +$58.6K ﹤0.01% 2852
2020
Q1
$217K Sell
14,705
-1,523
-9% -$31.9K ﹤0.01% 2983
2019
Q4
$429K Buy
16,228
+6,644
+69% +$153K ﹤0.01% 2838
2019
Q3
$223K Buy
9,584
+222
+2% +$5.03K ﹤0.01% 3193
2019
Q2
$230K Buy
9,362
+272
+3% +$6.28K ﹤0.01% 3164
2019
Q1
$206K Buy
9,090
+392
+5% +$8.93K ﹤0.01% 3225
2018
Q4
$210K Sell
8,698
-901
-9% -$20.8K ﹤0.01% 3102
2018
Q3
$239K Sell
9,599
-7,077
-42% -$180K ﹤0.01% 3184
2018
Q2
$409K Sell
16,676
-7
-0% -$163 ﹤0.01% 2820
2018
Q1
$373K Buy
16,683
+770
+5% +$18.1K ﹤0.01% 2751
2017
Q4
$397K Buy
15,913
+352
+2% +$7.96K ﹤0.01% 2672
2017
Q3
$353K Buy
15,561
+331
+2% +$7.97K ﹤0.01% 2686
2017
Q2
$377K Buy
15,230
+522
+4% +$12.9K ﹤0.01% 2583
2017
Q1
$370K Sell
14,708
-881
-6% -$21.3K ﹤0.01% 2565
2016
Q4
$337K Sell
15,589
-2,377
-13% -$51K ﹤0.01% 2564
2016
Q3
$410K Sell
17,966
-1,369
-7% -$31.1K ﹤0.01% 2408
2016
Q2
$386K Sell
19,335
-1,576
-8% -$31.6K ﹤0.01% 2249
2016
Q1
$412K Sell
20,911
-1,212
-5% -$22.5K ﹤0.01% 2146
2015
Q4
$491K Sell
22,123
-550
-2% -$9.95K ﹤0.01% 1997
2015
Q3
$397K Sell
22,673
-6,277
-22% -$129K ﹤0.01% 2022
2015
Q2
$630K Buy
28,950
+4,600
+19% +$110K ﹤0.01% 1976
2015
Q1
$653K Buy
24,350
+14,100
+138% +$371K ﹤0.01% 1904
2014
Q4
$297K Buy
+10,250
New +$293K ﹤0.01% 2137

Other funds holding WLKP

Raymond James & Associates's WLKP Position: Q3 2024 in Review

Raymond James & Associates reduced its Westlake Chemical Partners (WLKP) stake by 57% in Q3 2024, selling an estimated $575K and leaving 18,900 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #3201.

Raymond James & Associates first reported a position in WLKP in Q4 2014 and has held it in 38 quarters since. The position peaked at $1.15M in Q2 2022. 56 funds tracked by Wall St. Rank hold WLKP as of Q3 2024.

  • Raymond James & Associates held 18,900 shares of Westlake Chemical Partners worth $424K as of Q3 2024.
  • Raymond James & Associates sold 25,323 Westlake Chemical Partners shares in Q3 2024, an estimated $575K.
  • Westlake Chemical Partners made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3201 holding.
  • Raymond James & Associates first reported a position in Westlake Chemical Partners in Q4 2014 and has held it in 38 quarters since.
  • Raymond James & Associates's Westlake Chemical Partners position peaked at $1.15M in Q2 2022.
  • 56 funds tracked by Wall St. Rank held Westlake Chemical Partners as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.